EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine

Rohit Sharma, Sourabh Kumar, Kumari Komal, Rashmi Ghosh, Shubham Thakur, Ravi Raj Pal, Manish Kumar

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04094-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Rohit Sharma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, ISF College Pharmacy, GT Road, Moga, 142001, Punjab, India. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Nanomedicine, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 215 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is one of the most lethal malignancies worldwide. It is characterized by poor prognosis, high mortality, and recurrence rates. Various modifiable and non-modifiable risk factors are associated with pancreatic cancer incidence. Available treatments for pancreatic cancer include surgery, chemotherapy, radiotherapy, photodynamic therapy, supportive care, targeted therapy, and immunotherapy. However, the survival rates for PC are very low. Regrettably, despite efforts to enhance prognosis, the survival rate of pancreatic cancer remains relatively low. Therefore, it is essential to investigate new approaches to improve pancreatic cancer treatment. By synthesizing current knowledge and identifying existing gaps, this article provides a comprehensive overview of risk factors, pathology, conventional treatments, targeted therapies, and recent advancements in nanocarriers for its treatment, along with various clinical trials and patents that justify the safety and efficacy of innovative carriers for drug delivery systems. Ultimately, this review underscores the potential of these innovative formulations to improve outcomes and contribute significantly to the advancement of Pancreatic Cancer treatment. Together, these insights highlight nano-formulations as a promising frontier for effectively treating Pancreatic Cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNanomedicineAntineoplastic AgentsNanoparticlesDrug CarriersHumansAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

Active targetingChemotherapyLiposomeNanocarriersNanoparticlesPancreasPancreatic cancer

Substanzen

Antineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Department of Pharmaceutics, ISF College Pharmacy, GT Road, Moga, 142001, Punjab, India.
  • Department of Pharmaceutics, ISF College Pharmacy, GT Road, Moga, 142001, Punjab, India. manish_singh17@rediffmail.com.

Zitieren

APA

Sharma, R., Kumar, S., Komal, K., Ghosh, R., Thakur, S., Pal, R. R., & Kumar, M. (2025). Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04094-y

Vancouver

Sharma R, Kumar S, Komal K, Ghosh R, Thakur S, Pal RR, et al. Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04094-y

BibTeX
@article{Sharma2025,
  author = {Sharma, Rohit and Kumar, Sourabh and Komal, Kumari and Ghosh, Rashmi and Thakur, Shubham and Pal, Ravi Raj and Kumar, Manish},
  title = {Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04094-y}
}
Kostenlos starten →